# Study of Safety and Efficacy of the Drug Cycloferone in Patients with Acute Respiratory Viral Infection

> **NCT06286254** · — · COMPLETED · sponsor: **POLYSAN Scientific & Technological Pharmaceutical Company** · enrollment: 742 (actual)

## Conditions studied

- Acute Respiratory Viral Infection

## Interventions

- **DRUG:** Cycloferone

## Key facts

- **NCT ID:** NCT06286254
- **Lead sponsor:** POLYSAN Scientific & Technological Pharmaceutical Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-20
- **Primary completion:** 2024-04-20
- **Final completion:** 2024-09-30
- **Target enrollment:** 742 (ACTUAL)
- **Last updated:** 2024-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06286254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06286254, "Study of Safety and Efficacy of the Drug Cycloferone in Patients with Acute Respiratory Viral Infection". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06286254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*